4 October 2017
Sopharma AD notifies that for September 2017 the Company recorded an increase of sales revenues of 8% compared to the same month of 2016, including 1% decrease of domestic sales and 11% increase of export sales.
For the first nine months of this year, revenues from sales increased by 16% compared to the same period of 2016, including 2% increase of domestic sales and a 25% increase of export sales. After the merger of Medica AD, from the beginning of the year the Company recorded an increase of sales revenues of 25%, including 29% increase of export sales and 19% increase of domestic sales.